Ruxolitinib and Lenalidomide for Patients With Myelofibrosis

NCT01375140 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Myeloproliferative Diseases

Interventions

DRUG: Ruxolitinib
DRUG: Lenalidomide
DRUG: Prednisone

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]